Bicycle Therapeutics plc (BCYC)
NASDAQ: BCYC · Real-Time Price · USD
5.24
-0.12 (-2.24%)
At close: Feb 13, 2026, 4:00 PM EST
5.34
+0.10 (1.91%)
After-hours: Feb 13, 2026, 5:13 PM EST

Bicycle Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
3639677678791,790382
Market Cap Growth
-58.78%26.03%-12.72%-50.89%367.95%126.52%
Enterprise Value
-279872415611,563248
Last Close Price
5.2414.0018.0829.6060.8717.95
PS Ratio
12.8027.4028.4360.76152.9936.81
PB Ratio
0.591.222.073.255.174.01
P/TBV Ratio
0.591.222.073.255.174.01
EV/Sales Ratio
-2.468.9238.82133.6323.90
Debt / Equity Ratio
0.010.010.120.160.130.17
Asset Turnover
0.030.050.050.030.040.08
Quick Ratio
10.3313.617.926.7612.436.51
Current Ratio
10.6613.818.086.9312.656.73
Return on Equity (ROE)
-34.59%-29.04%-56.31%-36.54%-30.25%-54.08%
Return on Assets (ROA)
-20.59%-16.90%-23.60%-16.38%-12.80%-23.94%
Return on Capital Employed (ROCE)
-41.70%-23.60%-36.10%-32.70%-14.80%-37.60%
Earnings Yield
-68.96%-17.49%-23.55%-12.83%-3.73%-13.34%
FCF Yield
-66.54%-17.17%-8.29%-11.96%-0.94%-4.96%
Buyback Yield / Dilution
-34.28%-63.54%-20.00%-18.35%-30.90%-73.34%
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q